on a serious note....
where the hell is our first FSGS patient .....
6 months delay vs expectations.......this is nuts.....Atleast help us understand where the delay is!!
I am willing to bet anyone that our interim results won't be before end of 2024 at best at this rate of recruitment.... so essentially 18-24 months delay.... company won't say it but slowly they will keep pushing the interim analysis date in presentation out!!
and it will eventually become a cash flow issue !!
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-12
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.015(3.85%) |
Mkt cap ! $209.1M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 36.8¢ | $774.4K | 2.057M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 134968 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |